← Back to Search

Behavioural Intervention

Telehealth Treatment for Alcohol Use Disorder

N/A
Recruiting
Led By John Mendelson, MD
Research Sponsored by Ria Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up last four weeks
Awards & highlights

Summary

This trial will enroll people with alcohol use disorder and randomly assign them to either receive treatment through the Ria Treatment Platform or be placed on a waitlist. The Ria Treatment Platform uses telehealth to

Who is the study for?
This trial is for individuals with alcohol use disorder. Participants will be chosen randomly to either start the Ria Treatment Platform right away or be placed on a waitlist. The key requirement is having an alcohol use disorder; other specific criteria aren't listed.
What is being tested?
The study tests the Ria Treatment Platform, a telehealth service that includes medical assessments, medication, coaching sessions, educational content, and breathalyzer monitoring for three months against no immediate treatment (waitlist).
What are the potential side effects?
Potential side effects are not specified in this summary but may include reactions to medications used for treating alcohol use disorder within the telehealth program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~last four weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and last four weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
percent of subjects without heavy drinking

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Ria Treatment PlatfromExperimental Treatment1 Intervention
The Ria Treatment Platform is a telehealth approach that includes medical assessment, prescription of clinically appropriate medications for alcohol use disorder, individual and group coaching, educational video modules, and monitoring of breath alcohol concentrations through a Bluetooth-enabled breathalyzer.
Group II: waitlist controlActive Control1 Intervention
Patients in this arm will not be provided treatment during the study period.

Find a Location

Who is running the clinical trial?

Ria HealthLead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Alcoholism
40 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
823 Previous Clinical Trials
1,161,182 Total Patients Enrolled
432 Trials studying Alcoholism
778,343 Patients Enrolled for Alcoholism
Stanford UniversityOTHER
2,448 Previous Clinical Trials
17,492,270 Total Patients Enrolled
13 Trials studying Alcoholism
2,166 Patients Enrolled for Alcoholism
~72 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top